ILC1 cells from COVID-19 patients upregulated expression of CD6 (adj.p= 2.3e-06) (Figure 3A), which encodes a cell surface protein that has been shown to costimulate T cell activation and proliferation (24). This evidence concerns the gene CD6 and COVID-19.